Objective: The presence of cranial autonomic symptoms often leads to a misdiagnosis of "sinus headache" in adult migraineurs, leading to unnecessary treatments and delaying appropriate migraine therapy. In this study, we examined the frequency of cranial autonomic symptoms in pediatric/adolescent patients with migraine.
Study design and study population. We did a cross-sectional phenotyping of pediatric patients with migraine seen in 4 clinical settings during the study period (July 1, 2010 to June 30, 2012). All pediatric patients with migraine who were seen by one of us (A.A.G.) were included in this analysis.
Inclusion criteria were 1) age younger than 18 years; 2) diagnosis of migraine with or without aura by ICHD-II criteria for children 12 ; and 3) history regarding cranial autonomic symptoms obtained by A.A.G. at the clinical visit. Episodic migraine (,15 migraine days per month) and chronic migraine ($15 migraine days per month for $3 months) were defined by ICHD-II criteria for children, except medication overuse could be present in chronic migraine. Exclusion criteria were 1) age 18 years or older at initial evaluation, and 2) diagnosis that was not migraine.
There were 4 sites where patients were evaluated: 1) a general child neurology clinic at a local county hospital (San Francisco General Hospital); 2) a general child neurology clinic at a tertiary care facility (UCSF); 3) the inpatient pediatric ward or emergency department at a tertiary care facility (UCSF Benioff Children's Hospital); and 4) a subspecialty headache clinic associated with a tertiary care facility (UCSF Headache Clinic).
Determination of cranial autonomic symptoms. Pediatric patients were interviewed with at least one parent present. They were explicitly asked whether they ever experience each of the following symptoms with their headaches: 1) conjunctival injection, 2) lacrimation (apart from crying), 3) sense of grittiness or scratchiness in the eye, 15 4) nasal congestion, 5) rhinorrhea, 6) eyelid edema, 7) ptosis, 8) sense of ear fullness or pressure, and 9) facial sweating or flushing. Miosis was not explicitly asked about as ptosis was thought to be more easily noticed. Although a sense of grittiness or scratchiness in the eye is not included in the proposed definitions for cranial autonomic symptoms in ICHD-III, it was included here based on the opinion of the senior author that this symptom constitutes a cranial autonomic symptom.
If a symptom was noted by the patient or their parent(s) to be present, they were then asked whether the symptom occurred on 1) one side, 2) both sides, or whether it was 3) sometimes unilateral and sometimes bilateral. Whether it was the patient, the parent, or both who confirmed each symptom was not recorded. The frequency with which the patient experienced the symptom was also not recorded. Data analysis. All analyses were performed using Stata 12 (Sta-taCorp, College Station, TX). The x 2 , Fisher exact, and Student t tests were used as appropriate. Odds ratios (ORs) were calculated to determine whether any combination of 2 cranial autonomic symptoms seemed to occur more frequently than would be expected by chance.
RESULTS
One hundred thirty-three pediatric/ adolescent patients with migraine received initial headache evaluations during the study period. Eight were excluded because of missing data on the presence or absence of cranial autonomic symptoms. The remaining 125 patients constituted the study population. Demographic variables and clinical characteristics are shown in table 1.
Whereas a minority of children experienced strictly unilateral migraine headache (n 5 20, 16%), a more substantial group experienced unilateral headache at least some of the time (n 5 33, 26%), for a total of 53 (42%) who always or sometimes had unilateral headache. Patients with persistent unilateral headache and cranial autonomic symptoms always had the diagnosis of hemicrania continua considered and excluded in order to be included in this analysis.
When all 9 cranial autonomic symptoms were included, 73% (n 5 91) of pediatric migraineurs had at least one cranial autonomic symptom. The figure shows the prevalence of each cranial autonomic symptom.
When a sense of grit was removed from the analysis, 70% (n 5 87) had at least one cranial autonomic symptom. When a sense of aural fullness was also removed, reflecting current ICHD-II criteria, 62% (n 5 77) had at least one cranial autonomic symptom.
Because the upcoming ICHD-III criteria will include a sense of aural fullness as a cranial autonomic symptom, but not a sense of grit, all further analyses discussed below were performed using that group, i.e., sense of aural fullness included, sense of grit excluded.
Of these 87 patients, the majority experienced multiple cranial autonomic symptoms (n 5 49, 56%). Forty-four percent (n 5 38) had one cranial autonomic symptom, 28% (n 5 24) had 2, 14% (n 5 12) had 3, 6% (n 5 5) had 4, 8% (n 5 7) had 5, and 1% (n 5 1) had 7.
Of the 184 cranial autonomic symptoms experienced by these 87 patients, information on laterality was available for 163 of the symptoms. Twenty-three percent (n 5 38) were unilateral, 73% (n 5 119) bilateral, and 4% (n 5 6) varied between unilateral 
Site of initial evaluation
Pediatric headache subspecialty clinic
(49)
General child neurology clinic, university
(24)
General child neurology clinic, county 28 (22) Inpatient neurologic consultation 6 (5) a Data are n (%) unless otherwise indicated.
and bilateral. Further information on the laterality of each symptom is available in table 2.
Female sex, presence of aura, and having been evaluated at the headache subspecialty clinic did not increase the likelihood of having cranial autonomic symptoms. Age, treated both as a continuous variable and as a dichotomous variable (younger than 12 years vs 12-17 years), had no effect on the likelihood of having cranial autonomic symptoms (see table e-1 on the Neurology ® Web site at www.neurology.org). Those with chronic migraine were not more likely than those with episodic migraine to have cranial autonomic symptoms (74% vs 66%, p 5 0.31).
Similarly, a tendency to have unilateral headache, i.e., having headache that is sometimes or always unilateral, was not associated with increased likelihood of having cranial autonomic symptoms. The individual cranial autonomic symptoms were not more likely to be unilateral in those who had unilateral headache; however, the numbers in these analyses were quite small (table 3) .
Several cranial autonomic symptoms seemed more likely to co-occur (see table e-2). The OR of periorbital edema co-occurring with conjunctival injection was 6.5 (95% confidence interval [CI] 1.4-33.5), with a sense of aural fullness 7.7 (95% CI 1.6-48.5), and with facial flushing 16.4 (95% CI 2.9-163.5). The OR for ptosis and lacrimation co-occurring was 4.4 (95% CI 1.5-13), and for nasal congestion and rhinorrhea was 16.2 (95% CI 3.4-84.7). DISCUSSION The data show that approximately two-thirds of patients in pediatric/adolescent neurology or specialty headache practice with migraine have accompanying cranial autonomic symptoms. Given the frequent misdiagnosis of these symptoms in adults, 7-10 there is a very considerable possibility of similar widespread misdiagnosis in children. In fact, in a pediatric study, nearly 40% of migraineurs were initially misdiagnosed as having sinus headache. 11 Cranial autonomic symptoms arise from activation of the trigeminal-autonomic reflex, wherein nociceptive trigeminal afferents activate parasympathetic efferents carried by the seventh and eighth cranial nerves to target the lacrimal glands, nasal mucosa, and other areas. 2 Knowledge of the anatomy and physiology of the trigeminal-autonomic reflex offers clinicians insight into the clinical phenomenon of cranial autonomic symptoms and a simple, yet powerful tool with which to diagnose patients accurately. In fact, it may be that eye-related cranial autonomic symptoms are more likely to co-occur and noserelated cranial autonomic symptoms are more likely to co-occur than eye symptoms are to co-occur with nose symptoms. This would make sense neuroanatomically based on the V1 afferent involvement of eye-related symptoms and the V2 afferent involvement of nose-related symptoms. 16 Closer study of this issue is warranted.
Our study specifically targeted cranial autonomic symptoms in pediatric/adolescent migraineurs. Using current ICHD-II criteria for cranial autonomic symptoms, as they are explained in section 3 of the document, 62% of pediatric migraineurs had at least one cranial autonomic symptom. What is considered a cranial autonomic symptom is evolving. A sense of aural fullness will be added to the list of cranial autonomic symptoms in ICHD-III. 14 Including aural fullness in this analysis, the prevalence of cranial autonomic symptoms in pediatric migraineurs was 70%, and interestingly, it was the most common symptom. These figures are comparable to some studies in adults; for example, in one study, 73.1% of adult migraineurs had cranial autonomic symptoms. 4 Of note, in one study, 75% of adults migraineurs labeled as having sinus headache experienced cranial autonomic symptoms. 7 Moreover, in adult practice, such patients respond to treatment with sumatriptan. 17, 18 Given that sensory sensitivity symptoms, such as photophobia and phonophobia, are more often bilateral in migraineurs and unilateral in trigeminal autonomic cephalalgias, 19 it might be expected that cranial autonomic symptoms would also more likely be bilateral in migraineurs. Indeed, the majority of adult migraineurs experience bilateral cranial autonomic symptoms, in contrast to patients with trigeminal autonomic cephalalgias who more often experience these symptoms unilaterally. 6 In this pediatric study, the majority of pediatric cranial autonomic symptoms were also bilateral. In an adult study, strictly unilateral cranial autonomic symptoms were present in only 32% of adult migraineurs. 4 Similarly, in this pediatric study, only 23% of the cranial autonomic symptoms were strictly unilateral. This tendency for bilaterality may explain why studies that examined only for unilateral cranial autonomic symptoms in adult migraineurs reported a lower prevalence of cranial autonomic symptoms (26.9%-45.8% 3, 5 ).
The majority of affected patients in this study had more than one cranial autonomic symptom. Similarly, in adult studies, the majority of migraineurs with cranial autonomic symptoms express more than one symptom. [3] [4] [5] Age, sex, presence of aura, and having episodic vs chronic migraine did not predict likelihood of having cranial autonomic symptoms in this study. This is similar to adult studies wherein these variables were also not predictive. [4] [5] [6] Evaluation at the subspecialty headache clinic was also not predictive of having cranial autonomic symptoms in our study. In a population-based study of adults, 3 the prevalence of cranial autonomic symptoms reported was lower than in studies done in headache clinic populations 4, 5 ; however, this population-based study was limited in that only unilateral cranial autonomic symptoms were studied.
It is not surprising that a tendency for unilateral headache did not predict likelihood of having cranial autonomic symptoms in this pediatric study. In children, migraine headache is usually bilateral with the unilateral pattern more typical of adults emerging only in late adolescence or early adulthood. 12 Furthermore, even in adults, the association between unilateral migraine pain and cranial autonomic symptoms is inconsistent. [3] [4] [5] [6] One limitation of this study is that because trigeminal autonomic cephalalgias, such as cluster headache, paroxysmal hemicrania, and hemicrania continua, are rare in children, 20, 21 at this point, we were not able to make any comparisons between the frequency and characteristics of cranial autonomic symptoms in children with trigeminal autonomic cephalalgias vs migraine.
Although the compilation of our data was done after the fact, it has been our practice over many years to systematically seek cranial autonomic symptoms at the initial visit, so the clinical phenotyping was done prospectively. The data provide a glimpse of the frequency of cranial autonomic symptoms in pediatric/ adolescent migraineurs in a range of settings. The findings are in line with previous studies in adults. It is important for pediatricians and child neurologists to Table 3 Relationship between cranial autonomic symptom laterality and headache laterality Symptom ever unilateral in those whose headache is unilateral (some or all of the time), n (%) Symptom ever unilateral in those whose headache is never unilateral, n (%) be aware of the common nature of cranial autonomic symptoms in children with migraine to prevent misdiagnosis. "Sinus headache" is a common misdiagnosis given to both adult and pediatric migraineurs. [7] [8] [9] 11, 22 It has been theorized that this may be attributable to the tendency of both physicians and patients to associate ocular and nasal symptoms with sinusitis rather than with migraine, 23 together with a lack of awareness of the relevant anatomy and physiology. Misdiagnosing pediatric patients with migraine as having sinus headaches could lead to inappropriate and unnecessary treatments as well as delay in appropriate migraine therapy. In one adult study, 35% of the migraineurs had undergone previous sinus surgery, an example of the potential serious consequences of misdiagnosis. 7 In caring for young children with migraine, we must also be cognizant of the potential need to infer some of these symptoms from behavior, much as we infer photophobia and phonophobia from behavior in young children. For example, a young child who is pulling on an ear during a migraine could be experiencing a sense of aural fullness. A greater awareness of the anatomy and physiology of the trigeminalautonomic reflex, and its potential for activation in any trigeminal pain state, may save many children much suffering and numerous parents much angst.
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